首页> 外文期刊>International journal of biological sciences >Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells
【24h】

Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells

机译:TAB1在产生胰岛素的细胞中一氧化氮诱导的p38激活中的作用

获取原文
           

摘要

The aim of present study was to elucidate the role of TAB1 in nitric oxide-induced activation of p38 MAPK. For this purpose we over-expressed TAB1 in insulin-producing β-TC6 cells. We observed in cells transiently over-expressing TAB1 that p38 activation was enhanced in response to DETA/NONOate. A lowering of TAB1 levels, using the siRNA technique, resulted in the opposite effect. The DETA/NONOate-induced cell death rate was increased in cells transiently overexpressing TAB1. In stable β-TC6 cell clones with very high TAB1 levels p38 phosphorylation was enhanced also at basal conditions. DETA/NONOate increased also the phosphorylation of JNK and ERK in β-TC6 cells, but these events were not affected by TAB1. Interestingly, the inhibitory effect of SB203580 on p38 phosphorylation was paralleled by a stimulatory effect on JNK phosphorylation and an inhibitory effect on ERK phosphorylation. In summary, we propose that TAB1 promotes nitric oxide-induced p38 autophosphorylation. In addition, nitric oxide-induced p38 activation seems to promote JNK inhibition and ERK activation, but this effect appears to not require TAB1. A better understanding of how the TAB1/p38 pathway promotes β-cell death in response to nitric oxide might help in the development of novel pharmacological approaches in the treatment of diabetes.
机译:本研究的目的是阐明TAB1在一氧化氮诱导的p38 MAPK激活中的作用。为此,我们在产生胰岛素的β-TC6细胞中过表达TAB1。我们观察到瞬时过表达TAB1的细胞中,响应DETA / NONOate,p38激活增强。使用siRNA技术降低TAB1水平会产生相反的效果。在短暂过量表达TAB1的细胞中,DETA / NONOate诱导的细胞死亡率增加。在具有非常高的TAB1水平的稳定的β-TC6细胞克隆中,在基础条件下p38磷酸化也得到增强。 DETA / NONOate也增加了β-TC6细胞中JNK和ERK的磷酸化,但这些事件不受TAB1的影响。有趣的是,SB203580对p38磷酸化的抑制作用与对JNK磷酸化的刺激作用和对ERK磷酸化的抑制作用平行。总之,我们建议TAB1促进一氧化氮诱导的p38自磷酸化。此外,一氧化氮诱导的p38激活似乎可以促进JNK抑制和ERK激活,但是这种作用似乎不需要TAB1。更好地了解TAB1 / p38途径如何促进一氧化氮反应引起的β细胞死亡可能有助于开发治疗糖尿病的新药理学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号